These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37765052)

  • 1. The Impact of Relapses on Pain and Quality of Life in Patients with Multiple Sclerosis Treated with Corticosteroids.
    Rakusa M; Chataway J; Hardy TA
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.
    He A; Manouchehrinia A; Glaser A; Ciccarelli O; Butzkueven H; Hillert J; McKay KA
    JAMA Netw Open; 2023 Sep; 6(9):e2334675. PubMed ID: 37751208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder.
    Kim W; Park EY; Hyun JW; Huh SY; Park NY; Jang H; Kim SH; Kim HJ
    J Clin Neurol; 2020 Apr; 16(2):270-276. PubMed ID: 32319244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in multiple sclerosis: clinical and self-report scales.
    Neuteboom RF; Janssens AC; Siepman TA; Hoppenbrouwers IA; Ketelslegers IA; Jafari N; Steegers EA; de Groot CJ; Hintzen RQ
    J Neurol; 2012 Feb; 259(2):311-7. PubMed ID: 21811805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantifying the impact of upper limb tremor on the quality of life of people with multiple sclerosis: a comparison between the QUEST and MSIS-29 scales.
    Tang CC; Soh SE; Boonstra F; Noffs G; Kolbe SC; Butzkueven H; Evans A; Van der Walt A
    Mult Scler Relat Disord; 2022 Feb; 58():103495. PubMed ID: 35085981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine.
    Hobart J; Ziemssen T; Feys P; Linnebank M; Goodman AD; Farrell R; Hupperts R; Blight AR; Englishby V; McNeill M; Chang I; Lima G; Elkins J;
    CNS Drugs; 2019 Jan; 33(1):61-79. PubMed ID: 30535670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.
    Kaplan J; Miller T; Baker M; Due B; Zhao E
    Front Neurol; 2020; 11():598496. PubMed ID: 33414758
    [No Abstract]   [Full Text] [Related]  

  • 10. Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis.
    Binshalan T; Buckley E; Nair S; Mcneill A
    Cureus; 2024 Jan; 16(1):e51811. PubMed ID: 38322083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.
    Diržiuvienė B; Mickevičienė D
    Mult Scler Relat Disord; 2022 Mar; 59():103558. PubMed ID: 35123292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
    Burton JM; O'Connor PW; Hohol M; Beyene J
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006921. PubMed ID: 23235634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of a multiple sclerosis relapse: the patient's perspective.
    Oleen-Burkey M; Castelli-Haley J; Lage MJ; Johnson KP
    Patient; 2012; 5(1):57-69. PubMed ID: 22217263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.
    Nazareth TA; Rava AR; Polyakov JL; Banfe EN; Waltrip Ii RW; Zerkowski KB; Herbert LB
    Mult Scler Relat Disord; 2018 Nov; 26():219-234. PubMed ID: 30368080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes.
    Theodorsdottir A; Nielsen HH; Ravnborg MH; Illes Z
    Mult Scler Relat Disord; 2023 Mar; 71():104550. PubMed ID: 36842312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial.
    Yadav V; Marracci G; Kim E; Spain R; Cameron M; Overs S; Riddehough A; Li DK; McDougall J; Lovera J; Murchison C; Bourdette D
    Mult Scler Relat Disord; 2016 Sep; 9():80-90. PubMed ID: 27645350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.
    McKay KA; Ernstsson O; Manouchehrinia A; Olsson T; Hillert J
    Neurology; 2020 Mar; 94(9):e932-e941. PubMed ID: 31732567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
    Hoogervorst EL; Zwemmer JN; Jelles B; Polman CH; Uitdehaag BM
    Mult Scler; 2004 Oct; 10(5):569-74. PubMed ID: 15471375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies.
    Mäurer M; Comi G; Freedman MS; Kappos L; Olsson TP; Wolinsky JS; Miller AE; Dive-Pouletty C; Bozzi S; O'Connor PW
    Mult Scler Relat Disord; 2016 May; 7():33-40. PubMed ID: 27237754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.